BH
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| REPRESENT : REPresentativeness of RESearch data obtained through the 'General Informed ConsENT' | BMC medical ethics | 2023 | 157 | 191 | |||
| Universal test and treat and the HIV epidemic in rural South Africa : a phase 4, open-label, community cluster randomised trial | The lancet. HIV | 2018 | 80 | 122 | |||
| Ecthyma Gangrenosum: Escherichia coli or Pseudomonas aeruginosa? | Frontiers in Microbiology | 2017 | 617 | 271 | |||
| The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events | Journal of acquired immune deficiency syndromes | 2016 | 89 | 0 | |||
| Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy : The Swiss HIV Cohort Study | Open forum infectious diseases | 2016 | 89 | 112 | |||
| Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal | BMC public health | 2015 | 92 | 91 | |||
| Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study | European journal of clinical investigation | 2015 | 617 | 0 | |||
| HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons | BMC gastroenterology | 2015 | 83 | 39 | |||
| Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence | Lancet | 2015 | 673 | 0 | |||
| Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV | International journal of epidemiology | 2014 | 781 | 471 | |||
| Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone | HIV clinical trials | 2014 | 85 | 0 | |||
| Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence : the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa : study protocol for a cluster randomised controlled trial | Trials | 2013 | 111 | 27 | |||
| The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients | PLoS computational biology | 2013 | 715 | 308 | |||
| Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study | Neurology | 2013 | 830 | 1 | |||
| Capnocytophaga canimorsus prosthetic aortitis in an HIV-positive woman | Journal of clinical microbiology | 2013 | 723 | 308 | |||
| Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid | Journal of acquired immune deficiency syndromes and human retrovirology | 2013 | 603 | 0 | |||
| The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study | Antiviral therapy | 2013 | 757 | 0 | |||
| Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field | PloS one | 2013 | 820 | 1,193 | |||
| Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity* | HIV medicine | 2012 | 616 | 1 | |||
| Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia | AIDS | 2012 | 675 | 0 | |||
| Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine | PloS one | 2012 | 777 | 365 | |||
| Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations | Clinical infectious diseases | 2012 | 1,081 | 351 | |||
| Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | 2012 | 726 | 0 | |||
| Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections | AIDS | 2012 | 745 | 463 | |||
| Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B | Clinical infectious diseases | 2011 | 597 | 407 | |||
| Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection | Clinical infectious diseases | 2011 | 910 | 798 | |||
| Severe leptospirosis with multiple organ failure successfully treated by plasma exchange and high-volume hemofiltration | Case Reports in Nephrology and Dialysis | 2011 | 487 | 244 | |||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 1,056 | 668 | |||
| Ageing with HIV : medication use and risk for potential drug-drug interactions | The journal of antimicrobial chemotherapy | 2011 | 62 | 0 | |||
| Successful efavirenz dose reduction guided by therapeutic drug monitoring | Antiviral therapy | 2011 | 71 | 0 | |||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 884 | 8 | |||
| Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study | HIV medicine | 2011 | 652 | 0 | |||
| Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection | Gut | 2011 | 764 | 0 | |||
| VIH/SIDA : nombreuses nouveautés | Revue médicale suisse | 2011 | 78 | 162 | |||
| Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals: the Swiss HIV Cohort Study | Journal of translational medicine | 2011 | 670 | 324 | |||
| The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in Switzerland | The Journal of infectious diseases | 2011 | 683 | 630 | |||
| Human herpes virus type 8 seroprevalence in pregnant women in Geneva, Switzerland | Journal of maternal-fetal & neonatal medicine | 2011 | 664 | 0 | |||
| Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors | Journal of acquired immune deficiency syndromes | 2011 | 723 | 1,654 | |||
| No Longitudinal Mitochondrial DNA Sequence Changes in HIV-infected Individuals With and Without Lipoatrophy | Scandinavian journal of infectious diseases | 2011 | 987 | 364 | |||
| HIV treatment for prevention | Journal of the International AIDS Society | 2011 | 73 | 48 | |||
| Clinical relevance of cytomegalovirus viraemia | HIV medicine | 2011 | 661 | 0 | |||
| Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy | Gut | 2010 | 663 | 0 | |||
| Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2010 | 590 | 0 | |||
| Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir | AIDS | 2010 | 642 | 0 | |||
| Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections | The Journal of infectious diseases | 2010 | 660 | 0 | |||
| "Swiss statement": bilan deux ans après | Revue médicale suisse | 2010 | 599 | 0 | |||
| Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland | The Journal of infectious diseases | 2010 | 621 | 0 | |||
| Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load | PLOS pathogens | 2010 | 749 | 530 | |||
| HIV drugs for treatment, and for prevention | Lancet | 2010 | 616 | 0 | |||
| Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case report | Journal of medical case reports | 2010 | 747 | 332 | |||
| Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors | International journal of infectious diseases | 2010 | 609 | 0 | |||
| Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia | Clinical infectious diseases | 2010 | 621 | 0 | |||
| Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals | Clinical infectious diseases | 2010 | 659 | 0 | |||
| Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study | Clinical infectious diseases | 2010 | 618 | 0 | |||
| CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2 | Journal of acquired immune deficiency syndromes | 2010 | 627 | 0 | |||
| Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008 | Archives of internal medicine | 2010 | 562 | 0 | |||
| Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures | Journal of acquired immune deficiency syndromes | 2010 | 640 | 0 | |||
| No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial | HIV medicine | 2010 | 591 | 0 | |||
| Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection | Clinical infectious diseases | 2010 | 534 | 0 | |||
| Cognitive dysfunction in HIV patients despite long-standing suppression of viremia | AIDS | 2010 | 921 | 1 | |||
| Health perceptions of African HIV-infected patients and their physicians | Patient education and counseling | 2010 | 656 | 0 | |||
| Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study | Gastroenterology | 2010 | 899 | 0 | |||
| A new era of antiretroviral drug toxicity | Antiviral therapy | 2009 | 602 | 0 | |||
| Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy | Journal of clinical epidemiology | 2009 | 507 | 0 | |||
| Cas importés d'histoptasmose | Revue médicale suisse | 2009 | 633 | 0 | |||
| Is it smart to continue to study treatment interruptions? | AIDS | 2009 | 570 | 0 | |||
| Nouveau spectre des troubles cognitifs liés à l'infection par le VIH à l'ère des trithérapies | Revue médicale suisse | 2009 | 591 | 0 | |||
| Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study | HIV medicine | 2009 | 505 | 0 | |||
| Education thérapeutique en maladie infectieuse : l'exemple de l'infection à VIH | Revue médicale suisse | 2009 | 656 | 0 | |||
| HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial | AIDS | 2009 | 665 | 0 | |||
| The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection | AIDS | 2009 | 579 | 0 | |||
| Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples | Sexually transmitted infections | 2009 | 603 | 0 | |||
| VIH-sida | Revue médicale suisse | 2009 | 495 | 0 | |||
| Safety and efficacy of once-daily nevirapine dosing: a multicohort study | Antiviral therapy | 2009 | 662 | 0 | |||
| How reliable is an undetectable viral load? | HIV medicine | 2009 | 575 | 0 | |||
| Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine : a nested case-control study | Clinical infectious diseases | 2009 | 82 | 0 | |||
| Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007 | PloS one | 2009 | 1,134 | 830 | |||
| Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure | Hepatology | 2009 | 631 | 0 | |||
| Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study | Antiviral therapy | 2009 | 533 | 0 | |||
| Human herpes virus 8 replication during disseminated tuberculosis in a man with human immunodeficiency virus: a case report | Journal of medical case reports | 2009 | 690 | 605 | |||
| Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals | HIV clinical trials | 2009 | 533 | 0 | |||
| Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland | Clinical infectious diseases | 2009 | 645 | 0 | |||
| Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study | Circulation. Cardiovascular genetics | 2009 | 545 | 0 | |||
| Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV | Antiviral therapy | 2009 | 594 | 0 | |||
| The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients | The Open AIDS journal | 2009 | 693 | 458 | |||
| Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study | The Journal of infectious diseases | 2009 | 604 | 0 | |||
| HIV transmission under highly active antiretroviral therapy | Lancet | 2008 | 598 | 0 | |||
| Antiretroviral treatment during pregnancy | AIDS | 2008 | 680 | 0 | |||
| Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir | Clinical infectious diseases | 2008 | 592 | 0 | |||
| Dix ans de lipodystrophie (1998-2008) : un syndrome encore méconnu | Revue médicale suisse | 2008 | 594 | 236 | |||
| Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen | AIDS | 2008 | 563 | 0 | |||
| Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study | HIV medicine | 2008 | 608 | 0 | |||
| Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study | The Journal of infectious diseases | 2008 | 652 | 0 | |||
| Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir | Antiviral therapy | 2008 | 557 | 0 | |||
| Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy | British journal of cancer | 2008 | 650 | 0 | |||
| Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure | The Open virology journal | 2008 | 692 | 747 | |||
| Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study | HIV medicine | 2008 | 650 | 0 | |||
| Preference for CD4-guided versus continuous HARRT in Thailand | AIDS care | 2008 | 607 | 0 | |||
| Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection | AIDS | 2008 | 632 | 0 | |||
| The Monark trial: where now for boosted protease inhibitor monotherapy? | AIDS | 2008 | 561 | 0 | |||
| PEP ou pas PEP ? Du rationnel de l'emploi des prophylaxies postexpositionnelles | Revue médicale suisse | 2008 | 511 | 0 | |||
| Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting | International journal of STD & AIDS | 2008 | 625 | 0 | |||
| Initial treatment for HIV infection--an embarrassment of riches | The New England journal of medicine | 2008 | 608 | 0 | |||
| HIV transmission hunting--the chase for low risk events | Antiviral therapy | 2008 | 507 | 0 | |||
| Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era | AIDS | 2008 | 714 | 0 | |||
| HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy | Clinical infectious diseases | 2008 | 556 | 0 | |||
| Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study | Antiviral therapy | 2008 | 408 | 0 | |||
| Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy | The journal of antimicrobial chemotherapy | 2008 | 639 | 0 | |||
| HIV rebounds from latently infected cells, rather than from continuing low-level replication | Proceedings of the National Academy of Sciences of the United States of America | 2008 | 613 | 0 | |||
| Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients | Antiviral therapy | 2008 | 533 | 0 | |||
| Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection | The New England journal of medicine | 2008 | 693 | 0 | |||
| Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006 | HIV medicine | 2008 | 622 | 0 | |||
| CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy | Clinical infectious diseases | 2008 | 615 | 0 | |||
| Ferritin levels during structured treatment interruption of highly active antiretroviral therapy | HIV medicine | 2007 | 512 | 0 | |||
| Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy | Pharmacogenetics and genomics | 2007 | 631 | 0 | |||
| Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score | AIDS | 2007 | 523 | 0 | |||
| Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression | Journal of virology | 2007 | 594 | 0 | |||
| Clinical update: adverse effects of antiretroviral therapy | Lancet | 2007 | 631 | 0 | |||
| Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study | Antiviral therapy | 2007 | 626 | 0 | |||
| Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study | AIDS | 2007 | 594 | 0 | |||
| HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy | Journal of internal medicine | 2007 | 568 | 0 | |||
| No patient left behind--better treatments for resistant HIV infection | Lancet | 2007 | 576 | 0 | |||
| VIH – sida Traitement de l'infection à VIH en 2006 : points forts | Revue médicale suisse | 2007 | 572 | 0 | |||
| Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study | HIV clinical trials | 2007 | 587 | 0 | |||
| No change in calculated creatinine clearance after tenofovir initiation among Thai patients | The journal of antimicrobial chemotherapy | 2007 | 522 | 0 | |||
| Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study | Clinical infectious diseases | 2007 | 526 | 0 | |||
| Treatment interruption for convenience, cost cutting and toxicity sparing | Current opinion in HIV and AIDS | 2007 | 606 | 0 | |||
| HIV viral load monitoring in resource-limited regions: optional or necessary? | Clinical infectious diseases | 2007 | 631 | 1 | |||
| Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission | Clinical infectious diseases | 2007 | 583 | 0 | |||
| Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types | Archives of internal medicine | 2007 | 620 | 0 | |||
| Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study | Antiviral therapy | 2007 | 521 | 0 | |||
| CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy | Antiviral therapy | 2007 | 519 | 0 | |||
| Review on structured treatment interruptions (STIs) | Topics in HIV medicine | 2007 | 425 | 0 | |||
| Intermittent therapy for the treatment of chronic HIV infection | AIDS | 2007 | 580 | 0 | |||
| Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy | Antiviral therapy | 2007 | 567 | 0 | |||
| The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial | AIDS | 2007 | 648 | 0 | |||
| Late presentation of HIV-infected individuals | Antiviral therapy | 2007 | 536 | 0 | |||
| The trap: professional exposure to human immunodeficiency virus antibody negative blood with high viral load | Archives of internal medicine | 2007 | 497 | 0 | |||
| Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification | Antiviral therapy | 2007 | 592 | 1 | |||
| Increased incidence of sexually transmitted infections in Geneva, Switzerland | Dermatology | 2006 | 738 | 0 | |||
| Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study | HIV medicine | 2006 | 595 | 0 | |||
| Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study | Antiviral therapy | 2006 | 492 | 0 | |||
| HIV and solid organ transplantation: the Swiss experience | Schweizerische medizinische Wochenschrift | 2006 | 494 | 187 | |||
| Molecular biology of squamous cell carcinoma of the anus | British journal of surgery | 2006 | 782 | 0 | |||
| Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2006 | 482 | 0 | |||
| CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial | Lancet | 2006 | 672 | 0 | |||
| Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir | Antiviral therapy | 2006 | 553 | 0 | |||
| Immunological recovery and antiretroviral therapy in HIV-1 infection | Lancet. Infectious diseases | 2006 | 553 | 1 | |||
| Sida Molécules récentes, stratégies thérapeutiques d'avenir et nouvelles cibles du traitement | Revue médicale suisse | 2005 | 1,379 | 0 | |||
| Interrupting highly active antiretroviral therapy in patients with HIV | Expert review of anti-infective therapy | 2005 | 645 | 0 | |||
| Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study | Clinical infectious diseases | 2005 | 686 | 0 | |||
| Biphasic decline of CD4 cell count during scheduled treatment interruptions | AIDS | 2005 | 632 | 0 | |||
| Effect of rimonabant on weight reduction and cardiovascular risk | Lancet | 2005 | 541 | 0 | |||
| A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients | Antiviral therapy | 2005 | 542 | 0 | |||
| Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study | Journal of acquired immune deficiency syndromes | 2005 | 507 | 0 | |||
| Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders | The Journal of infectious diseases | 2005 | 513 | 0 | |||
| A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection | Clinical infectious diseases | 2005 | 629 | 0 | |||
| HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss | Journal of acquired immune deficiency syndromes | 2005 | 604 | 0 | |||
| Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study | Antiviral therapy | 2005 | 528 | 0 | |||
| Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions | Journal of virology | 2005 | 452 | 0 | |||
| Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir | AIDS | 2005 | 573 | 0 | |||
| Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection | Archives of dermatology | 2005 | 710 | 0 | |||
| Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study | Antiviral therapy | 2005 | 582 | 0 | |||
| Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy | Clinical infectious diseases | 2005 | 596 | 0 | |||
| Disseminated histoplasmosis in an HIV-infected patient discovered by routine blood smear staining | European journal of clinical microbiology & infectious diseases | 2005 | 582 | 283 | |||
| The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study | AIDS | 2004 | 625 | 0 | |||
| Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study | AIDS research and human retroviruses | 2004 | 654 | 0 | |||
| The incubation period of acute retroviral syndrome as a multistep process: a parametric survival analysis | Journal of acquired immune deficiency syndromes | 2004 | 614 | 0 | |||
| Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection | Antiviral therapy | 2004 | 486 | 0 | |||
| Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3 | Journal of acquired immune deficiency syndromes | 2004 | 606 | 0 | |||
| Antibiotics for acute rhinosinusitis | Archives of internal medicine | 2004 | 563 | 0 | |||
| Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study | BMJ. British medical journal | 2004 | 564 | 0 | |||
| Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg | Antiviral therapy | 2004 | 524 | 0 | |||
| Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point | Blood | 2004 | 632 | 0 | |||
| Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions | AIDS | 2004 | 634 | 0 | |||
| Infrequent transmission of HIV-1 drug-resistant variants | Antiviral therapy | 2004 | 616 | 0 | |||
| Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef | The Journal of infectious diseases | 2004 | 606 | 0 | |||
| Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 614 | 0 | |||
| Traitement par cidofovir topique d'infections cutanées à papillomavirus humain, poxvirus et Herpes simplex virus chez des malades séropositifs pour le VIH | Annales de dermatologie et de vénéréologie | 2004 | 844 | 0 | |||
| HIV-Primoinfektion | Therapeutische Umschau | 2004 | 587 | 0 | |||
| Is unsafe sexual behaviour increasing among HIV-infected individuals? | AIDS | 2004 | 589 | 0 | |||
| L-ornithine alpha-ketoglutarate in HIV infection: effects on muscle, gastrointestinal, and immune functions | Nutrition | 2004 | 677 | 0 | |||
| Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy | The Journal of infectious diseases | 2004 | 627 | 0 | |||
| Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily | The journal of antimicrobial chemotherapy | 2004 | 620 | 0 | |||
| HIV--vereinfachte bis gar keine Behandlung | Therapeutische Umschau | 2004 | 606 | 0 | |||
| A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART | AIDS | 2003 | 547 | 0 | |||
| Prophylaxie post-exposition au VIH | Revue médicale de la Suisse romande | 2003 | 617 | 0 | |||
| Beware of drug holidays before HIV salvage therapy | The New England journal of medicine | 2003 | 554 | 0 | |||
| Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions | The Journal of infectious diseases | 2003 | 597 | 0 | |||
| A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et al | AIDS | 2003 | 485 | 0 | |||
| Structured treatment interruptions in HIV infection: benefit or disappointment? | Expert review of anti-infective therapy | 2003 | 528 | 0 | |||
| Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection | Journal of virology | 2003 | 563 | 0 | |||
| Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population | Lancet | 2003 | 586 | 0 | |||
| Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2003 | 570 | 0 | |||
| Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et al | AIDS | 2003 | 442 | 0 | |||
| Caspofungin in the treatment of oropharyngeal candidiasis | International journal of clinical practice | 2003 | 592 | 0 | |||
| Antiretroviral treatment and research in resource-poor countries | Lancet | 2003 | 499 | 0 | |||
| Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivo | Antiviral therapy | 2003 | 540 | 0 | |||
| A prospective trial of structured treatment interruptions in human immunodeficiency virus infection | Archives of internal medicine | 2003 | 626 | 0 | |||
| Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial | AIDS | 2003 | 622 | 0 | |||
| Questions about the antimalarial amodiaquine | Lancet | 2003 | 475 | 0 | |||
| CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study | Archives of internal medicine | 2003 | 578 | 0 | |||
| Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS | Journal of acquired immune deficiency syndromes | 2003 | 665 | 0 | |||
| Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients, by Ghosn et al | AIDS | 2003 | 494 | 0 | |||
| Is autovaccination dead? | Research initiative, treatment action | 2003 | 485 | 0 | |||
| Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy | AIDS | 2003 | 548 | 0 | |||
| Drug resistance mutations during structured treatment interruptions | Antiviral therapy | 2003 | 557 | 0 | |||
| Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival | AIDS | 2003 | 548 | 0 | |||
| HIV RNA in plasma rebounds within days during structured treatment interruptions | AIDS | 2003 | 537 | 0 | |||
| Substitution for protease inhibitors in HIV therapy | The New England journal of medicine | 2003 | 574 | 0 | |||
| Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection | Clinical infectious diseases | 2003 | 573 | 0 | |||
| Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load | AIDS | 2002 | 525 | 0 | |||
| Supervised interruptions of antiretroviral therapy | AIDS | 2002 | 423 | 0 | |||
| Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection | Proceedings of the National Academy of Sciences of the United States of America | 2002 | 587 | 0 | |||
| Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national study | Nutrition | 2002 | 607 | 0 | |||
| Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) | AIDS | 2002 | 448 | 0 | |||
| New drugs, old drugs - dear drugs, cheap drugs | Schweizerische medizinische Wochenschrift | 2002 | 511 | 0 | |||
| The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual | AIDS | 2002 | 574 | 0 | |||
| Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age | Journal of acquired immune deficiency syndromes | 2002 | 622 | 0 | |||
| Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort | AIDS | 2002 | 590 | 0 | |||
| Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study | Antiviral therapy | 2002 | 480 | 0 | |||
| Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy | AIDS | 2002 | 572 | 0 | |||
| Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy | Journal of virology | 2002 | 536 | 0 | |||
| A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection | The Journal of infectious diseases | 2002 | 651 | 0 | |||
| Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study | HIV medicine | 2002 | 539 | 0 | |||
| A patient with HIV-1 superinfection | The New England journal of medicine | 2002 | 573 | 0 | |||
| Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2002 | 489 | 0 | |||
| Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study | AIDS | 2002 | 601 | 0 | |||
| Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load | Journal of clinical immunology | 2002 | 589 | 0 | |||
| Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts | Antiviral therapy | 2002 | 555 | 0 | |||
| Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load | European Journal of Immunology | 2001 | 528 | 0 | |||
| HIV transmission after suspension of highly active antiretroviral therapy | Journal of acquired immune deficiency syndromes | 2001 | 550 | 0 | |||
| Planned interruptions of anti-HIV treatment | Lancet. Infectious diseases | 2001 | 562 | 0 | |||
| Investigations of axillary and inguinal adenopathies during primary human immunodeficiency virus infection: other lymphadenopathies could bring additional information | The Journal of infectious diseases | 2001 | 568 | 0 | |||
| Modern anti-HIV therapy | Schweizerische medizinische Wochenschrift | 2001 | 552 | 0 | |||
| Fungemia in HIV-infected patients: a 12-year study in a tertiary care hospital | AIDS patient care and STDs | 2001 | 665 | 0 | |||
| Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000 | Schweizerische medizinische Wochenschrift | 2001 | 517 | 0 | |||
| Acute HIV infection: impact on the spread of HIV and transmission of drug resistance | AIDS | 2001 | 522 | 0 | |||
| Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study | Lancet | 2001 | 876 | 0 | |||
| Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study | AIDS | 2001 | 620 | 0 | |||
| Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients | HIV medicine | 2001 | 614 | 0 | |||
| Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study | Clinical infectious diseases | 2001 | 554 | 0 | |||
| Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis | European journal of clinical microbiology & infectious diseases | 2001 | 608 | 0 | |||
| Symptomes, signes cliniques et radiologiques prédictifs de l'origine bactérienne des rhino-sinusites aiguës | Schweizerische medizinische Wochenschrift | 2000 | 612 | 0 | |||
| Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study | AIDS | 2000 | 537 | 0 | |||
| Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates | AIDS | 2000 | 464 | 0 | |||
| Causes of macrocytosis in HIV-infected patients not treated with zidovudine. Swiss HIV Cohort Study | The Journal of infection | 2000 | 535 | 0 | |||
| Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS | The Journal of infectious diseases | 2000 | 683 | 0 | |||
| Regional differences in presentation of AIDS in Europe | Epidemiology and infection | 2000 | 585 | 0 | |||
| Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study | AIDS | 2000 | 495 | 0 | |||
| Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney | AIDS | 2000 | 594 | 0 | |||
| Zweitinfektion mit HIV: Mythos oder Realitat? | Schweizerische medizinische Wochenschrift | 2000 | 569 | 0 | |||
| Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection | AIDS | 2000 | 570 | 0 | |||
| VIH: épidemiologie et traitement--2000 | Revue médicale de la Suisse romande | 2000 | 517 | 0 | |||
| Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study | AIDS | 2000 | 560 | 0 | |||
| An annular plaque due to Mycobacterium haemophilum infection in a patient with AIDS | Journal of the American Academy of Dermatology | 2000 | 618 | 0 | |||
| Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group | Antimicrobial agents and chemotherapy | 2000 | 605 | 0 | |||
| Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study | Lancet | 2000 | 519 | 0 | |||
| Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study | The Journal of infectious diseases | 1999 | 585 | 0 | |||
| Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study | The New England journal of medicine | 1999 | 526 | 0 | |||
| A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy | The Journal of infectious diseases | 1999 | 536 | 0 | |||
| Prophylaxie post exposition au VIH: eligibilite des patients récemment infectés par voie sexuelle | Schweizerische medizinische Wochenschrift | 1999 | 738 | 0 | |||
| Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study | AIDS | 1999 | 508 | 0 | |||
| Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study | The Journal of infectious diseases | 1999 | 580 | 0 | |||
| The year in review: antiretroviral treatment | AIDS | 1999 | 508 | 0 | |||
| Detection of mycobacterial nucleic acids by polymerase chain reaction in fixed tissue specimens of patients with human immunodeficiency virus infection. Swiss HIV Cohort Study | Diagnostic molecular pathology | 1999 | 642 | 0 | |||
| AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study | JAMA | 1999 | 611 | 0 | |||
| Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection | Journal of acquired immune deficiency syndromes | 1999 | 536 | 0 | |||
| A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study | International journal of STD & AIDS | 1999 | 498 | 0 | |||
| Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study | AIDS | 1999 | 573 | 0 | |||
| Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense | Diagnostic microbiology and infectious disease | 1999 | 639 | 0 | |||
| Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study | Lancet | 1999 | 537 | 0 | |||
| Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group | Journal of acquired immune deficiency syndromes and human retrovirology | 1998 | 520 | 0 | |||
| A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study | AIDS | 1998 | 509 | 0 | |||
| A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study | AIDS | 1998 | 644 | 0 | |||
| Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study | AIDS | 1998 | 615 | 0 | |||
| Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study | Antiviral therapy | 1998 | 506 | 0 | |||
| Colour vision in AIDS patients without HIV retinopathy | Vision research | 1998 | 608 | 0 | |||
| Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen | The Journal of experimental medicine | 1998 | 518 | 0 | |||
| Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship | Clinical infectious diseases | 1998 | 576 | 0 | |||
| Microaerophilic conditions promote growth of Mycobacterium genavense | Journal of clinical microbiology | 1998 | 641 | 0 | |||
| 16S rRNA sequence diversity in Mycobacterium celatum strains caused by presence of two different copies of 16S rRNA gene | Journal of clinical microbiology | 1998 | 616 | 0 | |||
| Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV | The Journal of infectious diseases | 1998 | 620 | 0 | |||
| Radiological maxillary sinusitis in patients with common cold | Journal of family practice | 1998 | 548 | 0 | |||
| A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study | Archives of internal medicine | 1998 | 545 | 0 | |||
| Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy | The Journal of infectious diseases | 1998 | 561 | 0 | |||
| Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants | Journal of virology | 1998 | 568 | 0 | |||
| Progress and problems in the fight against AIDS | The New England journal of medicine | 1998 | 508 | 0 | |||
| Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995 | AIDS | 1998 | 674 | 2 | |||
| Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study | Journal of the American Academy of Dermatology | 1998 | 653 | 0 | |||
| Antiretroviral therapy: a guide to the most important trials | Schweizerische medizinische Wochenschrift | 1997 | 553 | 0 | |||
| Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study | AIDS | 1997 | 536 | 0 | |||
| Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine | Clinical microbiology and infection | 1997 | 679 | 0 | |||
| Adding saquinavir to stavudine in patients with advanced HIV-1 infection | AIDS | 1997 | 524 | 0 | |||
| HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study | American journal of respiratory and critical care medicine | 1997 | 592 | 0 | |||
| Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study | BMJ. British medical journal | 1997 | 553 | 0 | |||
| Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort | European Journal of Immunology | 1997 | 663 | 0 | |||
| Effet du traitement antirétroviral sur les manifestations électroencéphalographiques et otoneurologiques précoces de l'infection à VIH et signification pronostique des perturbations constatées | Neurophysiologie clinique | 1997 | 556 | 1 | |||
| Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures | Journal of clinical microbiology | 1997 | 579 | 0 | |||
| Detection of Mycobacterium avium-intracellulare in the blood of HIV-infected patients by a commercial polymerase chain reaction kit | European journal of clinical microbiology & infectious diseases | 1997 | 532 | 0 | |||
| Zidovudine plus didanosine in primary HIV-1 infection | Antiviral therapy | 1997 | 591 | 0 | |||
| Duration of hospitalization during the first two years after AIDS diagnosis: a descriptive study | Sozial- und Präventivmedizin | 1997 | 631 | 347 | |||
| Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? | Clinical infectious diseases | 1997 | 592 | 0 | |||
| Test tuberculinique, chimioprophylaxie antituberculeuse et incidence de la tuberculose dans l'étude suisse de cohorte VIH | Revue d'épidémiologie et de santé publique | 1997 | 510 | 0 | |||
| Chemotherapy for AIDS-related malignancies does not increase HIV viraemia | AIDS | 1997 | 510 | 0 | |||
| Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study Group | Clinical infectious diseases | 1997 | 538 | 0 | |||
| Two different 16S rRNA genes in a mycobacterial strain | Journal of clinical microbiology | 1996 | 601 | 0 | |||
| Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome | The Journal of infectious diseases | 1996 | 630 | 0 | |||
| Reasons for failure of prevention of Toxoplasma encephalitis. Swiss HIV Cohort Study | AIDS | 1996 | 580 | 0 | |||
| Disseminierte Infektion mit Mycobacterium celatum | Schweizerische medizinische Wochenschrift | 1996 | 635 | 0 | |||
| Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions | Lancet | 1996 | 653 | 1 | |||
| Cervical lymphadenitis caused by Mycobacterium genavense in a healthy child | The Pediatric infectious disease journal | 1996 | 652 | 0 | |||
| Prévalence de la transmission de virus résistant à la zidovudine en Suisse. L'étude suisse de cohorte VIH | Schweizerische medizinische Wochenschrift | 1996 | 566 | 0 | |||
| Combined therapy with zidovudine and L-697,661 in primary HIV infection | AIDS | 1996 | 587 | 0 | |||
| Controversies: does the CD4+ cell count reflect clinical efficacy? | JAMA | 1996 | 566 | 0 | |||
| Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients | Antiviral therapy | 1996 | 458 | 0 | |||
| Infection VIH, tuberculose et test tuberculinique en Suisse. The Swiss HIV Cohort Study | Schweizerische medizinische Wochenschrift | 1996 | 606 | 0 | |||
| Combination therapy in primary HIV infection | Antiviral research | 1996 | 587 | 0 | |||
| Risk factors for tuberculosis among HIV-infected patients in Switzerland. Swiss HIV Cohort Study | The European respiratory journal | 1996 | 601 | 0 | |||
| Capnocytophaga canimorsus sepsis complicated by myocardial infarction in two patients with normal coronary arteries | Clinical infectious diseases | 1996 | 683 | 0 | |||
| Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group | The Journal of infectious diseases | 1996 | 573 | 0 | |||
| Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey | Journal of clinical microbiology | 1996 | 596 | 0 | |||
| Red fingers syndrome in patients with HIV and hepatitis C infection | Lancet | 1996 | 647 | 0 | |||
| The risk of HIV transmission by screened blood | The New England journal of medicine | 1996 | 573 | 0 | |||
| Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir, and sorivudine | Clinical infectious diseases | 1996 | 636 | 0 | |||
| Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group | Tubercle and lung disease | 1996 | 559 | 0 | |||
| Fingertip necrosis during chemotherapy with bleomycin, vincristine and methotrexate for HIV-related Kaposi's sarcoma | British journal of dermatology | 1996 | 624 | 0 | |||
| Does dapsone increase mortality when given for prophylaxis of Pneumocystis carinii pneumonia? | AIDS | 1996 | 469 | 0 | |||
| HIV-related non-Hodgkin's lymphoma among European AIDS patients. AIDS in Europe Study Group. AIDS in Europe Study Group | European journal of haematology | 1995 | 561 | 0 | |||
| Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine | Journal of acquired immune deficiency syndromes and human retrovirology | 1995 | 627 | 0 | |||
| Human chronic gonadotropin for AIDS-related Kaposi's sarcoma | Lancet | 1995 | 552 | 0 | |||
| Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary? | Clinical microbiology and infection | 1995 | 568 | 0 | |||
| Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group | BMJ. British medical journal | 1995 | 582 | 0 | |||
| Pneumonia and respiratory distress syndrome during primary infection with Toxoplasma gondii | Clinical infectious diseases | 1995 | 544 | 0 | |||
| Infections à Mycobacterium genavense. Fréquence et présentation clinique | La Presse médicale | 1995 | 472 | 0 | |||
| Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients | Clinical infectious diseases | 1995 | 686 | 0 | |||
| Response of HIV RNA to didanosine as a predictive marker of survival | AIDS | 1995 | 660 | 0 | |||
| Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients | Antimicrobial agents and chemotherapy | 1994 | 609 | 0 | |||
| Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome | Medicine | 1992 | 608 | 0 | |||
| Hospital care for patients with AIDS compared to other patients in Geneva, 1981-1988 | AIDS | 1991 | 540 | 0 | |||
| A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia | The New England journal of medicine | 1991 | 655 | 0 | |||
| Anti-retrovirale Therapie in der Schweiz 1991 | Schweizerische medizinische Wochenschrift | 1991 | 547 | 0 | |||
| Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study | Annals of internal medicine | 1991 | 550 | 0 | |||
| Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective study | The Journal of infectious diseases | 1991 | 550 | 0 | |||
| Prophylaxe der infektiosen Reisekrankheiten | Therapeutische Umschau | 1991 | 505 | 0 | |||
| Complications neurologiques de l'infection par le virus d'immunodéficience humaine | La Presse médicale | 1991 | 475 | 0 | |||
| Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma | Klinische Wochenschrift | 1991 | 532 | 0 | |||
| Neuro-otological manifestations in different stages of HIV infection | Acta oto-laryngologica. Supplementum | 1991 | 636 | 0 | |||
| Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989 | AIDS | 1990 | 555 | 0 | |||
| Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome | The New England journal of medicine | 1990 | 662 | 194 | |||
| Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDS | Medizinische Klinik | 1990 | 481 | 0 | |||
| Antivirale Substanzen: Gegen was? Fur wen? | Therapeutische Umschau | 1990 | 556 | 0 | |||
| A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection | The New England journal of medicine | 1990 | 620 | 0 | |||
| Aids und Magendarmtrakt: eine Zusammenfassung fur Gastroenterologen und Chirurgen | Schweizerische medizinische Wochenschrift | 1990 | 554 | 0 | |||
| Indikationen und Kontraindikationen von Zidovudin | Deutsche Medizinische Wochenschrift | 1989 | 561 | 0 | |||
| HLA antigens are risk factors for development of AIDS | Journal of acquired immune deficiency syndromes | 1989 | 564 | 0 | |||
| Tuberculin skin reactivity in HIV-seropositive intravenous drug addicts | The New England journal of medicine | 1989 | 555 | 0 | |||
| Serum levels of ciprofloxacin after single oral doses in patients with septicemia | European journal of clinical microbiology & infectious diseases | 1989 | 695 | 0 | |||
| HIV screening in an emergency department | BMJ. British medical journal | 1988 | 497 | 0 | |||
| Négativation d'une sérologie positive pour le virus d'immunodéficience humaine (VIH). A propos de deux observations | Schweizerische medizinische Wochenschrift | 1988 | 982 | 0 | |||
| HIV infection: diagnosis and epidemiology | Seminars in hematology | 1988 | 410 | 0 | |||
| Antivirale Pharmaka--1988 | Schweizerische medizinische Wochenschrift | 1988 | 595 | 0 | |||
| Hepatische Manifestationen des erwobenen Immunmangelsyndroms (AIDS) | Schweizerische medizinische Wochenschrift | 1988 | 538 | 0 | |||
| Serological study of meningococcal isolates in Switzerland and France 1980-1986 | European journal of clinical microbiology & infectious diseases | 1988 | 658 | 0 | |||
| Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections | The Journal of infectious diseases | 1987 | 656 | 0 | |||
| Activation polyclonale B associee a l'infection par le virus d'immunodeficience humaine (VIH) | Schweizerische medizinische Wochenschrift | 1987 | 766 | 0 | |||
| Lymphadénopathies persistantes généralisées chez les homosexuels et les toxicomanes: altérations de l'immunité humorale et cellulaire | Schweizerische medizinische Wochenschrift | 1986 | 717 | 0 | |||
| Neopterin in AIDs, other immunodeficiencies, and bacterial and viral infections | Klinische Wochenschrift | 1986 | 625 | 0 | |||
| Amodiaquine and hepatitis | Annals of internal medicine | 1986 | 582 | 0 | |||
| Antikorper gegen das AIDS-Virus: Nachweismethoden und klinische Bedeutung | Therapeutische Umschau | 1986 | 566 | 0 | |||
| Altered functions of peripheral blood monocytes in homosexual males and intravenous drug users with persistent generalized lymphadenopathy | European journal of clinical investigation | 1986 | 696 | 0 | |||
| Air in the bones: multifocal anaerobic osteomyelitis associated with oat cell carcinoma | BMJ. British medical journal | 1985 | 578 | 0 | |||
| Listériose intraoculaire | Journal français d'ophtalmologie | 1985 | 559 | 0 | |||
| Typhusepidemiologie in der Schweiz 1980-1983. Geringe oder fehlende Wirksamkeit des Lebendimpfstoffes Vivotif bei Tropenreisenden | Schweizerische medizinische Wochenschrift | 1985 | 516 | 0 | |||
| Meningococcal meningitis in the first case of complement deficiency | Lancet | 1985 | 573 | 0 | |||
| Lymphadenopathic form of Kaposi's sarcoma (KS) in an African child. No evidence for acquired immunodeficiency syndrome (AIDS) | Helvetica paediatrica acta | 1985 | 589 | 0 | |||
| Vorbeugen ist teurer als heilen | Schweizerische medizinische Wochenschrift | 1985 | 544 | 0 | |||
| Prévention de l'hépatite B (HB): questions et réponses | Schweizerische Rundschau für Medizin PRAXIS | 1985 | 537 | 0 | |||
| Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever | European journal of clinical microbiology | 1985 | 663 | 0 | |||
| Syndrome de déficit immunitaire acquis, coccidiose chronique, et septicémie à Salmonella typhi murium chez un couple de zairois. Fonctions immunitaires et essai d'immunostimulation par la thymopentine | Schweizerische medizinische Wochenschrift | 1984 | 721 | 0 | |||
| Mesures à prendre avant un voyage au tiers monde | Schweizerische medizinische Wochenschrift | 1984 | 593 | 0 | |||
| Meningococcemia in a patient with acquired complement deficiency and myeloma | The New England journal of medicine | 1984 | 654 | 0 | |||
| Recurrent meningitis in an adult due to nontypable Haemophilus influenzae | The Journal of infectious diseases | 1984 | 610 | 0 | |||
| Cloning and analysis of the K1 capsule biosynthesis genes of Escherichia coli: lack of homology with Neisseria meningitidis group B DNA sequences | Infection and immunity | 1983 | 592 | 0 | |||
| Neisseria meningitidis B et E. coli K1: des gènes différents mais régissant la production d'une capsule identique. Communication préliminaire | Schweizerische medizinische Wochenschrift | 1983 | 559 | 0 | |||
| Septicémie à anaérobes après infections oropharyngées (septicémie post-angine de Lemierre): un syndrome oublié | Schweizerische medizinische Wochenschrift | 1983 | 760 | 0 | |||
| Syndrome de déficience immunitaire acquise et infections opportunistes chez une femme | Schweizerische medizinische Wochenschrift | 1983 | 546 | 0 | |||
| Typhus abdominalis nach Impfung mit dem Lebend-Impfstoff Vivotif | Schweizerische medizinische Wochenschrift | 1983 | 594 | 0 | |||
| Failures with oral typhoid vaccine Ty 21a | Lancet | 1983 | 630 | 0 | |||
| Cointegrate formation by Tn5, but not transposition, is dependent on recA | Proceedings of the National Academy of Sciences of the United States of America | 1982 | 696 | 1 | |||
| Structure and stability of transposon 5-mediated cointegrates | Journal of Molecular Biology | 1982 | 596 | 0 | |||
| Granulation tissue as a contractile organ. A study of structure and function | The Journal of experimental medicine | 1972 | 637 | 0 | |||
| Fibroblasts of granulation tissue: immunofluorescent staining with antismooth muscle serum | Proceedings of the Society for Experimental Biology and Medicine | 1971 | 627 | 0 | |||
| Contraction of granulation tissue in vitro: similarity to smooth muscle | Science | 1971 | 703 | 0 |
